Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Induction of the transcription factor Irf8 in the common dendritic cell progenitor (CDP) is required for classical type 1 dendritic cell (cDC1) fate specification, but the mechanisms controlling this induction are unclear. In the present study Irf8 enhancers were identified via chromatin profiling of dendritic cells and CRISPR/Cas9 genome editing was used to assess their roles in Irf8 regulation. An enhancer 32 kilobases (kb) downstream of the Irf8 transcriptional start site (+32-kb Irf8) that was active in mature cDC1s was required for the development of this lineage, but not for its specification. Instead, a +41-kb Irf8 enhancer, previously thought to be active only in plasmacytoid dendritic cells, was found to also be transiently accessible in cDC1 progenitors, and deleting this enhancer prevented the induction of Irf8 in CDPs and abolished cDC1 specification. Thus, cryptic activation of the +41-kb Irf8 enhancer in dendritic cell progenitors is responsible for cDC1 fate specification.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6707878PMC
http://dx.doi.org/10.1038/s41590-019-0450-xDOI Listing

Publication Analysis

Top Keywords

irf8 enhancer
12
cdc1 fate
12
fate specification
12
dendritic cell
12
irf8
9
cryptic activation
8
dendritic cells
8
+41-kb irf8
8
enhancer
5
cdc1
5

Similar Publications

Gasdermin D (GSDMD), an effector molecule of cell pyroptosis, is known to be activated in various cells during inflammation. However, the patterns of GSDMD activation in immune regulatory cells such as myeloid-derived suppressor cells (MDSCs) remain unclear. In this study, we found that neutrophils in colorectal cancer (CRC) tissues exhibited reduced GSDMD transcription, as evidenced by a single-cell RNA sequencing result.

View Article and Find Full Text PDF

Background: Hepatitis B virus (HBV) modulates immune epigenetic landscape. Therefore, we investigated immune epigenetic landscape in HBsAg seroconverters and non-seroconverters.

Methods: Sixteen rHBV patients including seroconverters (SC,  = 7) and non-seroconverters (NSC,  = 9) at baseline and week 24 were recruited.

View Article and Find Full Text PDF

Cis- and trans-regulation of Irf8 enhancers during dendritic cell development.

Exp Hematol

July 2025

Department of Immunology, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan; Advanced Medical Research Center, Yokohama City University, Yokohama, Kanagawa, Japan.

Dendritic cells (DCs) are mononuclear phagocytes that play a crucial role in the immune system by mediating innate and adaptive immunity. DC differentiation requires the establishment of DC-specific gene expression regulated by lineage-specific transcription factors. Recent studies have reported a series of transcription factors essential for DC differentiation, as well as the regulatory circuit composed of these transcription factors.

View Article and Find Full Text PDF

The efficacy of Chimeric Antigen Receptor T cells against solid tumors is limited by immunosuppressive factors in the tumor microenvironment including adenosine, which suppresses Chimeric Antigen Receptor T cells through activation of the A receptor. To overcome this, Chimeric Antigen Receptor T cells are engineered to express A receptor, a receptor that signals inversely to A receptor. Using murine and human Chimeric Antigen Receptor T cells, constitutive A receptor overexpression significantly enhances Chimeric Antigen Receptor T cell effector function albeit at the expense of Chimeric Antigen Receptor T cell persistence.

View Article and Find Full Text PDF

Background: Macrophages play central roles in the immunity response to infection of intracellular bacteria, including Mycobacterium tuberculosis (M.tb) in tuberculosis (TB). Methyltransferase-like 3 (METTL3) has been implicated in the macrophage regulation in TB, and this study intended to investigate the molecular mechanism of METTL3 with interferon regulatory factor-8 (IRF8) in TB using in vitro model established by M.

View Article and Find Full Text PDF